0001256071-23-000002.txt : 20230209
0001256071-23-000002.hdr.sgml : 20230209
20230209103120
ACCESSION NUMBER: 0001256071-23-000002
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230209
DATE AS OF CHANGE: 20230209
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Icosavax, Inc.
CENTRAL INDEX KEY: 0001786255
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-92771
FILM NUMBER: 23601899
BUSINESS ADDRESS:
STREET 1: 1930 BOREN AVE., SUITE 1000
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: (206) 737-0085
MAIL ADDRESS:
STREET 1: 1930 BOREN AVE., SUITE 1000
CITY: SEATTLE
STATE: WA
ZIP: 98101
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: PLATINUM INVESTMENT MANAGEMENT LTD
CENTRAL INDEX KEY: 0001256071
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: C/O PLATINUM ASSET MANAGEMENT
STREET 2: LEVEL 8, 7 MACQUARIE PLACE
CITY: SYDNEY AUSTRALIA 2000
STATE: C3
ZIP: 00000
BUSINESS PHONE: 61292557533
MAIL ADDRESS:
STREET 1: C/O PLATINUM ASSET MANAGEMENT
STREET 2: LEVEL 8, 7 MACQUARIE PLACE
CITY: SYDNEY AUSTRALIA 2000
STATE: C3
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: PLATINUM ASSET MANAGEMENT LTD
DATE OF NAME CHANGE: 20030722
SC 13G
1
Icosavax11.txt
SC 13G
Schedule 13G
Name of issuer: Icosavax, Inc.
Title of class of securities: Common Stock
Cusip: 45114M109
Date of event which requires filing: 12/31/2022
Rule 13d-1(b)
1. Platinum Investment Management Limited
2. (b)
3.
4. Sydney Australia
5. Platinum Investment Management Limited
2,095,181 (5.25%)
Note:Combined total of underlying managed funds
6. N/A
7. Platinum Investment Management Limited
2,249,711 (5.64%)
Note:Combined total of underlying managed funds
8. N/A
9. 2,249,711
10. No
11. 5.64%
12. IA
Item 1.
(a) Icosavax, Inc.
(b) 1930 BOREN AVE.
SUITE 1000
SEATTLE,
WA 98101
USA
Item 2.
(a) Platinum Investment Management Limited
(b) Level 8, 7 Macquarie Place
Sydney NSW 2000
Australia
(c) Australia
(d) Common Stock
(e) 45114M109
Item 3.
(e) An IA in accordance with Section 240.13d-1(b)(1)(ii)(e)
Item 4.
(a) 2,249,711
(b) 5.64%
(c) (i) 2,095,181
(ii) 0
(iii) 2,249,711
(iv) 0
Item 5
No
Item 6
The clients of Platinum Investment Management Ltd including pooled
investment vehicles and other managed accounts have the right to
receive or power to direct the receipt of dividends from, and the
proceeds from the sale of, Icosavax, Inc.
Item 7
N/A
Item 8
N/A
Item 9
N/A
Item 10
(a) By signing below, I certify that to the best of my knowledge and
belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
(b) N/A
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information
set forth in this statement is true, complete and correct.